KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $5.71 $8.43 Friday, 26th Apr 2024 RLAY stock ended at $6.37. This is 3.49% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.32% from a day low at $6.01 to a day high of $6.51.
90 days $5.71 $11.16
52 weeks $5.71 $13.32

Historical Relay Therapeutics Inc. prices

Date Open High Low Close Volume
Apr 26, 2024 $6.15 $6.51 $6.01 $6.37 745 224
Apr 25, 2024 $6.16 $6.21 $5.82 $6.16 1 349 345
Apr 24, 2024 $5.87 $6.43 $5.71 $6.35 1 705 684
Apr 23, 2024 $5.97 $6.01 $5.86 $5.90 782 653
Apr 22, 2024 $6.02 $6.07 $5.78 $5.95 1 004 014
Apr 19, 2024 $6.10 $6.34 $5.93 $5.96 2 321 258
Apr 18, 2024 $6.15 $6.40 $5.95 $6.11 2 767 606
Apr 17, 2024 $6.69 $6.77 $6.20 $6.21 1 859 203
Apr 16, 2024 $6.72 $7.00 $6.62 $6.74 1 162 242
Apr 15, 2024 $7.04 $7.16 $6.70 $6.83 657 865
Apr 12, 2024 $7.17 $7.18 $6.98 $7.03 872 768
Apr 11, 2024 $7.03 $7.15 $6.79 $7.13 728 646
Apr 10, 2024 $6.97 $7.05 $6.81 $6.90 963 325
Apr 09, 2024 $7.17 $7.38 $7.12 $7.31 645 171
Apr 08, 2024 $6.96 $7.22 $6.79 $7.19 928 901
Apr 05, 2024 $6.86 $7.22 $6.75 $6.90 1 409 387
Apr 04, 2024 $7.21 $7.36 $6.95 $6.96 1 526 063
Apr 03, 2024 $7.50 $7.53 $7.05 $7.14 1 858 943
Apr 02, 2024 $7.81 $7.81 $7.53 $7.60 814 109
Apr 01, 2024 $8.30 $8.30 $7.92 $8.02 782 952
Mar 28, 2024 $8.06 $8.43 $7.99 $8.30 649 478
Mar 27, 2024 $7.70 $8.21 $7.57 $8.16 988 150
Mar 26, 2024 $7.60 $7.83 $7.50 $7.57 1 639 011
Mar 25, 2024 $7.78 $8.01 $7.50 $7.53 1 108 836
Mar 22, 2024 $8.00 $8.05 $7.77 $7.79 808 273
Click to get the best stock tips daily for free!

About Relay Therapeutics Inc.

Relay Therapeutics. Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for pa... RLAY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT